235 related articles for article (PubMed ID: 15314893)
1. Refractory anemia and the myelodysplastic syndromes.
Lawrence LW
Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
[TBL] [Abstract][Full Text] [Related]
2. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
Zeidan AM; Battiwalla M; Berlyne D; Winkler T
Leuk Res; 2017 Feb; 53():8-12. PubMed ID: 27923195
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and classification of myelodysplastic syndromes.
Hasserjian RP; Germing U; Malcovati L
Blood; 2023 Dec; 142(26):2247-2257. PubMed ID: 37774372
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndromes: clinical practice guidelines in oncology.
Greenberg PL; Attar E; Bennett JM; Bloomfield CD; Borate U; De Castro CM; Deeg HJ; Frankfurt O; Gaensler K; Garcia-Manero G; Gore SD; Head D; Komrokji R; Maness LJ; Millenson M; O'Donnell MR; Shami PJ; Stein BL; Stone RM; Thompson JE; Westervelt P; Wheeler B; Shead DA; Naganuma M
J Natl Compr Canc Netw; 2013 Jul; 11(7):838-74. PubMed ID: 23847220
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Tseng MH; Kuo YY; Yu SC; Liu MC; Yuan CT; Yang YT; Chuang MK; Ko BS; Tang JL; Sun HI; Chuang YK; Tien HF; Hou HA; Chou WC
Blood Cancer J; 2024 Apr; 14(1):57. PubMed ID: 38594285
[TBL] [Abstract][Full Text] [Related]
6. Current challenges and unmet medical needs in myelodysplastic syndromes.
Platzbecker U; Kubasch AS; Homer-Bouthiette C; Prebet T
Leukemia; 2021 Aug; 35(8):2182-2198. PubMed ID: 34045662
[TBL] [Abstract][Full Text] [Related]
7. A rare case of acquired immunodeficiency associated with myelodysplastic syndrome.
Li J; Li J; Li J; Yao H; Liu F; Gusella JF; Shi X; Chen X
Mol Genet Genomic Med; 2019 Nov; 7(11):e923. PubMed ID: 31503426
[TBL] [Abstract][Full Text] [Related]
8. The Evolving Landscape of Myelodysplastic Syndrome Prognostication.
Shreve J; Nazha A
Clin Hematol Int; 2020 Jun; 2(2):43-48. PubMed ID: 32879911
[TBL] [Abstract][Full Text] [Related]
9. Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic Syndromes.
Ridgeway JA; Tinsley S; Kurtin SE
J Adv Pract Oncol; 2017; 8(1):29-39. PubMed ID: 29900015
[TBL] [Abstract][Full Text] [Related]
10. When Clinico-Morphological and Molecular Studies Tell Different Stories: A Case of Myelodysplastic Syndrome.
Jain N; Gautam P; Tiwari A; Mittal A; Gupta N; Yadav ML
Int J Appl Basic Med Res; 2022; 12(4):288-290. PubMed ID: 36726663
[TBL] [Abstract][Full Text] [Related]
11. Computational analysis of peripheral blood smears detects disease-associated cytomorphologies.
de Almeida JG; Gudgin E; Besser M; Dunn WG; Cooper J; Haferlach T; Vassiliou GS; Gerstung M
Nat Commun; 2023 Jul; 14(1):4378. PubMed ID: 37474506
[TBL] [Abstract][Full Text] [Related]
12. Genomic imbalances in peripheral blood confirm the diagnosis of myelodysplastic syndrome in a patient presenting with non-immune hemolytic anemia.
Zahid MF; Khan N; Pei J; Testa JR; Dulaimi E
Leuk Res Rep; 2016; 5():23-6. PubMed ID: 27298759
[TBL] [Abstract][Full Text] [Related]
13. Successful cord blood transplantation for del7q myelodysplastic syndrome in Pearson marrow pancreas syndrome.
Belgacem ZH; Dubois SM; Jacoby E; Martin PL; Parikh SB; Fleming MD; Agarwal S
Am J Hematol; 2023 Dec; 98(12):E376-E379. PubMed ID: 37732815
[No Abstract] [Full Text] [Related]
14. Myelodysplastic Syndromes and Modalities of Treatment: An Updated Literature Review.
Zamora DI; Patel GS; Grossmann I; Rodriguez K; Soni M; Joshi PK; Patel SC; Shreya D; Sange I
Cureus; 2021 Dec; 13(12):e20116. PubMed ID: 34873563
[TBL] [Abstract][Full Text] [Related]
15. Hypercellular bone marrow in aplastic anemia: A case report of two patients.
Sweeney R; Esmail F; Mirza KM; Nand S
Clin Case Rep; 2021 Nov; 9(11):e04845. PubMed ID: 34853682
[TBL] [Abstract][Full Text] [Related]
16. Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms.
Niscola P; Gianfelici V; Giovannini M; Piccioni D; Mazzone C; de Fabritiis P
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672645
[TBL] [Abstract][Full Text] [Related]
17. The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.
Nachtkamp K; Strupp C; Vukelja M; Kasprzak A; Haase D; Ganster C; Hildebrandt B; Betz B; Giagounidis A; Aul C; Blum S; Hofmann WK; Pfeilstöcker M; Valent P; Lübbert M; Seidl M; Rudelius M; Stauder R; Krieger O; Götze KS; Bobak J; Kündgen A; Schulz F; Dietrich S; Kobbe G; Gattermann N; Germing U
Leukemia; 2024 Feb; 38(2):442-445. PubMed ID: 38263435
[No Abstract] [Full Text] [Related]
18. [Optimal cut-off points of CD34 and CD117 in the differential diagnosis between hypocellular myelodysplastic syndrome and aplastic anemia].
Wang W; Zhu P; Gu JW; Wang XQ
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):75-77. PubMed ID: 28219233
[No Abstract] [Full Text] [Related]
19. Refractory anemia in the elderly.
Gardner FH
Adv Intern Med; 1987; 32():155-75. PubMed ID: 3548248
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplasic syndromes: a comprehensive review.
Catenacci DV; Schiller GJ
Blood Rev; 2005 Nov; 19(6):301-19. PubMed ID: 15885860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
